Celldex Therapeutics Inc (CLDX)
Healthcare
Biotechnology
37.70 $
-1.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Celldex Therapeutics Inc (CLDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -66 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27 | -19 | -33 | -41 | -29 | -55 | -32 | -54 | -44 | -49 | -64 | -66 | -222 | |
| 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | -12 | 0.8 | 0.9 | 0.9 | 0.8 | 3.9 | 0.2 | 5.8 | |
| 5.2 | 7.1 | 7.2 | 7.2 | 7.6 | 9.6 | 9.8 | 9.3 | 9.2 | 8.8 | 8.9 | 8.5 | 35 | |
| 5.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.5 | 13 | 5.0 | -13 | 2.8 | -19 | 7.4 | -8.5 | 4.2 | 9.8 | 8.5 | 4.3 | 27 | |
| 0.4 | 0.2 | 0.7 | 0.3 | 0.3 | 0.6 | 0.8 | 0.3 | 0.7 | 0.4 | 1.0 | 1.6 | 3.8 | |
| 1.2 | 12 | -171 | -315 | -47 | 48 | 24 | 43 | 50 | 61 | 55 | 72 | 238 | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | 0.3 | 217 | 436 | 3.7 | 1.2 | 0.4 | 0.2 | 0.1 | 0.8 | 1.3 | 0.3 | 2.5 | |
| -26 | -7.1 | 14 | 80 | -72 | -6.3 | -8.0 | -11 | 5.9 | 13 | -7.2 | 6.9 | 19 | |
| -28 | -19 | -33 | -41 | -30 | -55 | -33 | -55 | -45 | -49 | -65 | -67 | -226 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.